Rhythm Pharmaceuticals (RYTM) Interest Coverage Ratio (2022 - 2025)
Historic Interest Coverage Ratio for Rhythm Pharmaceuticals (RYTM) over the last 4 years, with Q3 2025 value amounting to 11.1.
- Rhythm Pharmaceuticals' Interest Coverage Ratio fell 3263.02% to 11.1 in Q3 2025 from the same period last year, while for Sep 2025 it was 8.7, marking a year-over-year increase of 3728.67%. This contributed to the annual value of 12.89 for FY2024, which is 289.44% up from last year.
- Latest data reveals that Rhythm Pharmaceuticals reported Interest Coverage Ratio of 11.1 as of Q3 2025, which was down 3263.02% from 7.79 recorded in Q2 2025.
- In the past 5 years, Rhythm Pharmaceuticals' Interest Coverage Ratio ranged from a high of 7.57 in Q4 2024 and a low of 980.35 during Q2 2022
- Moreover, its 4-year median value for Interest Coverage Ratio was 12.53 (2023), whereas its average is 82.05.
- Its Interest Coverage Ratio has fluctuated over the past 5 years, first surged by 9856.08% in 2023, then plummeted by 7142.51% in 2024.
- Quarter analysis of 4 years shows Rhythm Pharmaceuticals' Interest Coverage Ratio stood at 13.98 in 2022, then surged by 35.14% to 9.07 in 2023, then grew by 16.49% to 7.57 in 2024, then tumbled by 46.6% to 11.1 in 2025.
- Its Interest Coverage Ratio was 11.1 in Q3 2025, compared to 7.79 in Q2 2025 and 8.69 in Q1 2025.